Trial NCT02610426
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- Phase
- Not given
- Sponsor
- National Cancer Institute (NCI)
- Conditions
- Breast Carcinoma
- Ages
- Any age
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* European American patients with DNA available
* European American patients who developed CHF and patients who did not develop CHF following a full course of treatment with an anthracycline and bevacizumab
* African American cases (based on a drop in left ventricular ejection fraction [LVEF] < 50 or a drop from baseline > 20 points) and African American controlsCardiac
Restrictions found (1)
- CardiacOutrightinclusion
LVEF < 50 or drop from baseline > 20 points
Show in the text
Recruiting in Massachusetts
- Eastern Cooperative Oncology Group · Boston, Suffolk County